TSE:AEZS

Aeterna Zentaris (AEZS) Stock Price, News & Analysis

C$11.57
+0.02 (+0.17%)
(As of 05/17/2024 08:55 PM ET)
Today's Range
C$11.57
C$11.60
50-Day Range
C$2.60
C$11.79
52-Week Range
C$7.64
C$16.92
Volume
1,610 shs
Average Volume
624 shs
Market Capitalization
C$14.00 million
P/E Ratio
N/A
Dividend Yield
2.79%
Price Target
N/A
AEZS stock logo

About Aeterna Zentaris Stock (TSE:AEZS)

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications; and AEZS-150, a delayed clearance parathyroid hormonefusion polypeptide that is in preclinical trail for the treatment of hypoparathyroidism in adults. Aeterna Zentaris Inc. has a license agreement with University of Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the Republic of Korea; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria EOOD for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults in Turkey and some non-European Union Balkan countries; as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

AEZS Stock Price History

AEZS Stock News Headlines

Aeterna Zentaris Finalizes Some Details for Ceapro Merger
Court Approves Ceapro-Aeterna Merger - Quick Facts
Closing Bell: Aeterna Zentaris Inc flat on Monday (AEZS)
Aeterna Zentaris, Ceapro to Combine
Aeterna Zentaris Enters Into Merger Agreement With Ceapro
See More Headlines
Receive AEZS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Net Income
C$-16,550,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$4.50 million
Cash Flow
C$25.24 per share
Book Value
C$14.99 per share

Miscellaneous

Free Float
N/A
Market Cap
C$14.00 million
Optionable
Not Optionable
Beta
2.08
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Klaus Paulini Ph.D.
    President, CEO & Executive Director
  • Mr. Giuliano La Fratta
    Senior VP of Finance & CFO
  • Dr. Michael Teifel Ph.D.
    Senior VP of Non-Clinical Development & Chief Scientific Officer
  • Dr. Nicola Ammer M.D.
    Chief Medical Officer & Senior VP of Clinical Development
  • Dr. Matthias Gerlach
    Senior Vice President Manufacturing & Supply Chain

AEZS Stock Analysis - Frequently Asked Questions

How have AEZS shares performed in 2024?

Aeterna Zentaris' stock was trading at C$2.57 at the beginning of 2024. Since then, AEZS stock has increased by 350.2% and is now trading at C$11.57.
View the best growth stocks for 2024 here
.

How do I buy shares of Aeterna Zentaris?

Shares of AEZS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:AEZS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners